Clinical Trials for Refractory Acute Myeloid Leukemia

Find clinical trials for refractory acute myeloid leukemia. Discover research opportunities and treatment options in your area.

45 Active Trials Found

Showing 45 trials on this page

Page 3 of 3

VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS

NCT ID: NCT06536959

This clinical trial is testing a new treatment for patients with relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS). The researchers are looking at a ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML

NCT ID: NCT06418776

The IMPACT-AML clinical trial is studying the effectiveness and safety of two different treatment approaches for adults with relapsed or refractory acute myeloid leukemia (AML), a type of blood can...

Recruiting

Phase: PHASE3 Type: interventional Locations: Moscow, , Russian Federation

Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML

NCT ID: NCT06385808

This clinical trial is investigating a new treatment approach called the MTBF conditioning regimen for patients with relapsed or refractory acute myeloid leukemia (AML). This means the trial is foc...

Not yet recruiting

Phase: NA Type: interventional

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies

NCT ID: NCT04470947

The EXALT-2 clinical trial is studying new treatment options for patients with aggressive blood cancers such as advanced lymphoma and leukemia that have not responded to previous therapies. This tr...

Recruiting

Type: observational Locations: Vienna, , Austria

Palbociclib or Tazemetostat in Combination With CPX-351 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

NCT ID: NCT05627232

This clinical trial is looking at the safety and effectiveness of two drugs, palbociclib or tazemetostat, when combined with a chemotherapy treatment called CPX-351 for patients with acute myeloid ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions